US Broker Ratings

Sprinklr, Inc. (CXM) Stock Analysis: Unveiling a 44.74% Potential Upside in the Cloud Software Sector

Sprinklr, Inc. (NYSE: CXM), a key player in the technology sector’s software application industry, has been capturing investor attention with its robust growth potential and strategic market positioning. Headquartered in..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Biotechnology Innovator with Over 300% Potential Upside

aTyr Pharma, Inc. (NASDAQ: ATYR) is a niche player in the biotechnology sector, commanding attention for its cutting-edge approach to tRNA synthetase biology with the aim to develop novel therapies..

Sanara MedTech Inc. (SMTI) Stock Analysis: A Promising 69.84% Upside Potential in the Medical Technology Sector

Sanara MedTech Inc. (NASDAQ: SMTI) is attracting investor attention with its significant potential upside and promising developments in the medical technology sector. Despite a current price of $29.44, analysts have..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Potential 276% Upside Beckons Investors

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical firm headquartered in San Diego, is capturing the attention of investors with its impressive potential upside of 276.57%. Specializing in the healthcare..

WeRide Inc. (WRD) Stock Analysis: Autonomous Driving Pioneer with a 49.68% Upside Potential

WeRide Inc. (NASDAQ: WRD) is emerging as a compelling narrative in the autonomous driving sector, leveraging its innovative technology platform to revolutionize transportation. With a market capitalization of $3.47 billion,..

Marti Technologies, Inc. (MRT) Stock Analysis: A Potential 107% Upside Drives Investor Interest

Marti Technologies, Inc. (MRT), a burgeoning player in the tech-enabled urban transportation sector, is making waves in Turkey’s mobility landscape. With a market cap of $189.69 million, Marti is focusing..

HubSpot, Inc. (HUBS) Stock Analysis: Exploring a 47.3% Upside with Strong Buy Ratings

HubSpot, Inc. (NYSE: HUBS), a leading provider of cloud-based customer relationship management (CRM) platforms, stands as a beacon of innovation within the technology sector. With a market capitalization of $24.56..

Porch Group, Inc. (PRCH) Stock Analysis: A Potential 28.92% Upside Beckons Investors

Porch Group, Inc. (NASDAQ: PRCH) presents a compelling investment opportunity within the technology sector, specifically in the software application industry. With a market capitalization of $1.6 billion, Porch Group stands..

A2Z Cust2Mate Solutions Corp. (AZ) Investor Outlook: Exploring a Potential 175.86% Upside

A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology company specializing in retail smart cart solutions, has been garnering attention from investors for its innovative approach and promising growth potential. Operating..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Compelling 374% Upside Potential for Biotechnology Investors

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a prominent player in the biotechnology sector, is garnering attention from investors due to its robust pipeline and a remarkable potential upside. The company,..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Navigating a Promising 27.81% Upside Potential

Investors with a keen eye on the healthcare sector might find Cytek Biosciences, Inc. (NASDAQ: CTKB) an intriguing opportunity. This Fremont, California-based company, with a market cap of $510.17 million,..

Spok Holdings, Inc. (SPOK) Stock Analysis: Exploring a 32.83% Upside in Healthcare Communication

Spok Holdings, Inc. (NASDAQ: SPOK) is a company that offers critical communication solutions primarily serving the healthcare sector. Headquartered in Plano, Texas, Spok Holdings is recognized for its innovative services..

Domo, Inc. (DOMO) Stock Analysis: Exploring a 33% Potential Upside for Tech Investors

Domo, Inc. (NASDAQ: DOMO), a notable player in the technology sector, operates within the software application industry, offering a robust cloud-based platform designed to enhance data connectivity and business intelligence..

Applovin Corporation (APP): Investor Outlook on High Growth Potential and Strategic Market Positioning

AppLovin Corporation (NASDAQ: APP), a key player in the Communication Services sector, stands out in the advertising agencies industry with its innovative suite of marketing and monetization solutions. As the..

TruBridge, Inc. (TBRG) Stock Analysis: Healthcare Solutions Provider with 26.99% Potential Upside

TruBridge, Inc. (NASDAQ: TBRG), a key player in the healthcare sector, offers a diverse array of information services that cater to community hospitals, clinics, and a variety of healthcare systems..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 11.12% Potential Upside in the Energy Sector

TotalEnergies SE (NYSE: TTE) stands as a formidable player in the integrated oil and gas industry, with a market capitalization of $134.62 billion. Based in France, this multi-energy company has..

Asana, Inc. (ASAN) Investor Outlook: Analyzing a Potential 18% Upside

Asana, Inc. (NYSE: ASAN), a prominent player in the Technology sector’s Software – Application industry, presents a compelling case for investors seeking growth opportunities in the fast-evolving work management software..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Exploring a 57.98% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) has emerged as a notable player within the biotechnology sector, focusing on innovative treatments for gastrointestinal diseases. Headquartered in Florham Park, New Jersey, this biopharmaceutical..

Yalla Group Limited (YALA) Stock Analysis: Exploring a 26.77% Potential Upside with Robust Revenue Growth

Investors focusing on the dynamic intersection of social networking and gaming should keep a keen eye on Yalla Group Limited (NYSE: YALA). Headquartered in Dubai, this tech company is carving..

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Navigating a 38.68% Potential Upside in the Biotech Sector

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, is drawing attention in the biotechnology sector with its innovative approach to targeting genetically defined diseases. Headquartered in Cambridge, Massachusetts, Fulcrum..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds